We suggest that investors who own GSK's stock remain invested for now, considering its sales and profits are expected to continue improving in the coming years.

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...

GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... asked about the postponed tariffs at a White House press conference, President Trump said: “The tariffs are going ...

GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi (SGIOY) as ...

Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...

ViiV Healthcare has announced promising results from two Phase IIa studies of investigational antiretroviral therapies, VH184 ...

The Dow Jones Industrial Average lost 0.6% and the S&P 500 shed 1.1% ahead of tonight’s Federal Reserve interest rate ...

Stocks gained on Wednesday ahead of the Federal Reserve’s interest rate announcement at 2 p.m., which will be followed by Fed ...

The FTSE 100 index is 31.14 points lower at 8674.09, a worse-than-expected performance amid the selling of stocks including ...